Skip to main content

VRTX Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Vertex Pharmaceuticals Incorporated News

bluebird bio (Finally) Nears Approval. What's Next?

The gene therapy pioneer may earn approval years after initially teasing investors. It may not be time to celebrate.

Best Buy, Tyson Make Goldman List of Margin of Safety Stocks

The stocks could thrive amid the current uncertainty in the equity market and the economy, Goldman says.

Cathie Wood Watch: Ark Buys a Sagging Healthcare Stock

Ark did more selling than buying on April 29, including sale of a South African financial services company's stock.

Cathie Wood Watch: This Firm Programs Cells, Using DNA as Code

Wood's Ark Investment Management bought a series of biotech stocks, as it has done repeatedly in recent sessions.

Vertex Has a Pain Pill That May Replace Opioids

Vertex is one step closer to getting its new pain pill approved, which could substitute for opioids that are highly addictive.

Breaking News

Roe Decision Forces Disney, Netflix to Take a Political Stand

Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.

Netflix Lays Offs More Employees To Cut Costs

Netflix layoffs continue as the streaming giant executes a plan to cope with slow revenue growth.

These Five Things Could Help (or Hurt) Internet Stocks

Bank of America analysts outline some of the biggest issues facing Amazon, Alphabet, Meta and other internet-related stocks.